Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.

Bertinetti C, Simon F, Zirlik K, Heining-Mikesch K, Pfeifer D, Osterroth F, Rosenthal FM, Veelken H.

Eur J Haematol. 2006 Nov;77(5):395-402. Epub 2006 Jul 27.

PMID:
16879605
2.

Lack of effector cell function and altered tetramer binding of tumor-infiltrating lymphocytes.

Blohm U, Roth E, Brommer K, Dumrese T, Rosenthal FM, Pircher H.

J Immunol. 2002 Nov 15;169(10):5522-30.

3.

Cytokine gene transfer in cancer therapy.

Cao L, Kulmburg P, Veelken H, Mackensen A, Mézes B, Lindemann A, Mertelsmann R, Rosenthal FM.

Stem Cells. 1998;16 Suppl 1:251-60. Review.

4.

Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo.

Prévost-Blondel A, Roth E, Rosenthal FM, Pircher H.

J Immunol. 2000 Apr 1;164(7):3645-51.

5.

Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.

Prévost-Blondel A, Zimmermann C, Stemmer C, Kulmburg P, Rosenthal FM, Pircher H.

J Immunol. 1998 Sep 1;161(5):2187-94.

6.

Cloning and sequence analysis of the immediate promoter region and cDNA of porcine granulocyte colony-stimulating factor.

Kulmburg P, Radke M, Mezes B, Mertelsmann R, Rosenthal FM.

Gene. 1997 Sep 15;197(1-2):361-5.

PMID:
9332386
7.
8.

Collagen as matrix for neo-organ formation by gene-transfected fibroblasts.

Rosenthal FM, Köhler G.

Anticancer Res. 1997 Mar-Apr;17(2A):1179-86.

PMID:
9137468
9.

NTS influence on transgene expression from mono- and bicistronic plasmid vectors after lipofection in a human fibroblast cell line.

Kulmburg P, Veelken H, Schmoor C, Rosenthal FM, Mackensen A, Lindemann A, Mertelsmann R.

J Mol Med (Berl). 1997 Mar;75(3):223-9.

PMID:
9106079
10.

A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer.

Veelken H, Mackensen A, Lahn M, Köhler G, Becker D, Franke B, Brennscheidt U, Kulmburg P, Rosenthal FM, Keller H, Hasse J, Schultze-Seemann W, Farthmann EH, Mertelsmann R, Lindemann A.

Int J Cancer. 1997 Jan 27;70(3):269-77.

11.

Processing of tumor tissues for vaccination with autologous tumor cells.

Lahn M, Köhler G, Schmoor C, Dengler W, Veelken H, Brennscheidt U, Mackensen A, Kulmburg P, Hentrich I, Jesuiter H, Rosenthal FM, Fiebig HH, Sommerkamp H, Farthmann EH, Hasse J, Mertelsmann R, Lindemann.

Eur Surg Res. 1997;29(4):292-302.

PMID:
9257102
12.

Systemic hematological effects of granulocyte colony-stimulating factor produced by irradiated gene-transfected fibroblasts.

Rosenthal FM, Kulmburg P, Früh R, Pfeifer C, Veelken H, Mackensen A, Köhler G, Lindemann A, Mertelsmann R.

Hum Gene Ther. 1996 Nov 10;7(17):2147-56.

PMID:
8934228
13.

Systematic evaluation of chimeric marker genes on dicistronic transcription units for regulated expression of transgenes in vitro and in vivo.

Veelken H, Re D, Kulmburg P, Rosenthal FM, Mackensen A, Mertelsmann R, Lindemann A.

Hum Gene Ther. 1996 Oct 1;7(15):1827-36.

PMID:
8894674
14.

In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type.

Herbst B, Köhler G, Mackensen A, Veelken H, Kulmburg P, Rosenthal FM, Schaefer HE, Mertelsmann R, Fisch P, Lindemann A.

Blood. 1996 Oct 1;88(7):2541-8.

PMID:
8839846
15.

Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro.

Mackensen A, Herbst B, Köhler G, Wolff-Vorbeck G, Rosenthal FM, Veelken H, Kulmburg P, Schaefer HE, Mertelsmann R, Lindemann A.

Blood. 1995 Oct 1;86(7):2699-707.

PMID:
7545468
16.

Guidelines for the design and implementation of clinical studies in somatic cell therapy and gene therapy. The German Working Group for Gene Therapy.

Lindemann A, Rosenthal FM, Hase S, Markmeyer P, Mertelsmann R.

J Mol Med (Berl). 1995 Apr;73(4):207-11. No abstract available.

PMID:
7627642
17.

Pilot study for the evaluation of T-cell-mediated tumor immunotherapy by cytokine gene transfer in patients with malignant tumors.

Mertelsmann R, Lindemann A, Boehm T, Brennscheidt U, Franke B, Kulmburg P, Lahn M, Mackensen A, Rosenthal FM, Veelken H.

J Mol Med (Berl). 1995 Apr;73(4):205-6. No abstract available.

PMID:
7627641
18.

[References for planning and implementation of clinical studies in somatic cell and gene therapy].

Lindemann A, Rosenthal FM, Hase S, Markmeyer P, Mertelsmann R.

Med Klin (Munich). 1995 Feb 15;90(2):103-6. German. No abstract available.

PMID:
7708000
19.

[References for planning and implementation of clinical studies in the areas of somatic cell and gene therapy. German Society of Gene Therapy].

Lindemann A, Rosenthal FM, Hase S, Markmeyer P, Mertelsmann R.

Chirurg. 1995 Jan;66(1):71-5. German. No abstract available.

PMID:
7889797
20.

Cytokine therapy with gene-transfected cells: single injection of irradiated granulocyte-macrophage colony-stimulating factor-transduced cells accelerates hematopoietic recovery after cytotoxic chemotherapy in mice.

Rosenthal FM, Früh R, Henschler R, Veelken H, Kulmburg P, Mackensen A, Gansbacher B, Mertelsmann R, Lindemann A.

Blood. 1994 Nov 1;84(9):2960-5.

PMID:
7949168
21.

Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicity.

Rosenthal FM, Zier KS, Gansbacher B.

Curr Opin Oncol. 1994 Nov;6(6):611-5. Review.

PMID:
7827174
22.

Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines.

Saito S, Bannerji R, Gansbacher B, Rosenthal FM, Romanenko P, Heston WD, Fair WR, Gilboa E.

Cancer Res. 1994 Jul 1;54(13):3516-20.

23.

Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.

Vieweg J, Rosenthal FM, Bannerji R, Heston WD, Fair WR, Gansbacher B, Gilboa E.

Cancer Res. 1994 Apr 1;54(7):1760-5.

24.

Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs.

Rosenthal FM, Cronin K, Bannerji R, Golde DW, Gansbacher B.

Blood. 1994 Mar 1;83(5):1289-98.

PMID:
8118032
25.

Tumor-bearing animals contain suppressed antitumor effectors the function of which can be unmasked by IL-2.

Salvadori S, Rosenthal FM, Cronin K, Gansbacher B, Zier KS.

J Immunother Emphasis Tumor Immunol. 1993 Oct;14(3):216-20.

PMID:
8297903
26.

Retroviral vector-mediated cytokine-gene transfer into tumor cells.

Gansbacher B, Rosenthal FM, Zier K.

Cancer Invest. 1993;11(3):345-54. Review. No abstract available.

PMID:
8485657
27.

Combination of interleukin-2 and interferon-alpha in renal cell carcinoma and malignant melanoma: a phase II clinical trial.

Veelken H, Rosenthal FM, Schneller F, von Schilling C, Guettler IC, Herrmann F, Mertelsmann R, Lindemann A.

Biotechnol Ther. 1992;3(1-2):1-14.

PMID:
1305889
28.

The role of cytokines in oncology.

Lange W, Brugger W, Rosenthal FM, Kanz L, Lindemann A.

Int J Cell Cloning. 1991 Jul;9(4):252-73. Review.

PMID:
1894956
29.

Cytokines and hematopoietins: physiology, pathophysiology, and potential as therapeutic agents.

Mertelsmann R, Rosenthal FM, Lindemann A, Herrmann F.

Recent Results Cancer Res. 1991;121:121-40. Review. No abstract available.

PMID:
1857854
30.

Clinical role of colony stimulating factors.

Brugger W, Rosenthal FM, Kanz L, Mertelsmann R.

Acta Haematol. 1991;86(3):138-47. Review. No abstract available.

PMID:
1785228

Supplemental Content

Loading ...
Support Center